Westport Advisers’s AbbVie ABBV Stock Holding History

Westport Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-180,000	Closed	-$10.5M	–	50
2015 Q1	$10.5M	Hold	180,000	–	–	1.1%	33
2014 Q4	$11.8M	Hold	180,000	–	–	1.2%	32
2014 Q3	$10.4M	Hold	180,000	–	–	1.03%	37
2014 Q2	$10.2M	Hold	180,000	–	–	0.97%	38
2014 Q1	$9.25M	Hold	180,000	–	–	0.88%	41
2013 Q4	$9.51M	Hold	180,000	–	–	0.86%	41
2013 Q3	$8.05M	Hold	180,000	–	–	0.74%	44
2013 Q2	$7.44M	Buy	+180,000	New	+$7.87M	0.72%	47

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westport Advisers's ABBV Position: Q2 2015 in Review

Westport Advisers sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 180,000 shares — an estimated $10.5M sold.

Westport Advisers first reported a position in ABBV in Q2 2013 and held it in 8 quarters. The position peaked at $11.8M in Q4 2014. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Westport Advisers reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
Westport Advisers sold 180,000 AbbVie shares in Q2 2015, an estimated $10.5M.
Westport Advisers first reported a position in AbbVie in Q2 2013 and held it in 8 quarters.
Westport Advisers's AbbVie position peaked at $11.8M in Q4 2014.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Westport Advisers's 13F filing for Q2 2015, filed 12 Aug 2015.